2022
Local recurrence of uveal melanoma and concomitant brain metastases associated with an activating telomerase promoter mutation seven years after secondary enucleation
Heng JS, Perzia BM, Sinard JH, Pointdujour-Lim R. Local recurrence of uveal melanoma and concomitant brain metastases associated with an activating telomerase promoter mutation seven years after secondary enucleation. American Journal Of Ophthalmology Case Reports 2022, 27: 101607. PMID: 35707052, PMCID: PMC9189986, DOI: 10.1016/j.ajoc.2022.101607.Peer-Reviewed Original ResearchConcomitant brain metastasesOptic nerve massRecurrent uveal melanomaLocal recurrenceSecondary enucleationUveal melanomaBrain metastasesSystemic metastasesNerve massMultiple mass lesionsOptic nerve invasionYear old patientNext-generation sequencingSeven yearsNerve invasionExtrascleral extensionGait instabilityMass lesionPrimary tumorPatient historyAnophthalmic socketHigh riskRecurrenceEnucleationMetastasis
2019
Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
Kim JM, Weiss S, Sinard JH, Pointdujour-Lim R. Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma. Ocular Oncology And Pathology 2019, 6: 35-38. PMID: 32002403, PMCID: PMC6984155, DOI: 10.1159/000497473.Peer-Reviewed Original Research